EGFR and melanoma: Conversely, genes of the EGFR and TGF-ß pathways involved in melanoma progression and targeted drug resistance16,24 were induced by DAB treatment in AR overexpressing cells, to a much greater extent than in control cells (Fig. 5b, Supplementary Data 2).